Transcription factors in ferroptotic cell death
Cancer Gene Therapy, Published online: 03 March 2020; doi:10.1038/s41417-020-0170-2Transcription factors in ferroptotic cell death (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - March 3, 2020 Category: Cancer & Oncology Authors: Chongshan Dai Xin Chen Jingbo Li Paul Comish Rui Kang Daolin Tang Source Type: research

Reviewer Recognition
Cancer Gene Therapy, Published online: 21 February 2020; doi:10.1038/s41417-020-0168-9Reviewer Recognition (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - February 21, 2020 Category: Cancer & Oncology Authors: Georgios Giamas Source Type: research

Cancer Gene Therapy: vision and strategy for the new decade
Cancer Gene Therapy, Published online: 18 February 2020; doi:10.1038/s41417-020-0169-8Cancer Gene Therapy: vision and strategy for the new decade (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - February 18, 2020 Category: Cancer & Oncology Authors: Georgios Giamas Source Type: research

Non-toxic fragment of botulinum neurotoxin type A and monomethyl auristatin E conjugate for targeted therapy for neuroendocrine tumors
Cancer Gene Therapy, Published online: 07 February 2020; doi:10.1038/s41417-020-0167-xNon-toxic fragment of botulinum neurotoxin type A and monomethyl auristatin E conjugate for targeted therapy for neuroendocrine tumors (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - February 7, 2020 Category: Cancer & Oncology Authors: Jason Whitt Won S. Hong Rahul R. Telange Chee Paul Lin James Bibb David J. Beebe Herbert Chen Renata Jaskula-Sztul Source Type: research

Correction: Specific driving of the suicide E gene by the CEA promoter enhances the effects of paclitaxel in lung cancer
Cancer Gene Therapy, Published online: 06 February 2020; doi:10.1038/s41417-020-0166-yCorrection: Specific driving of the suicide E gene by the CEA promoter enhances the effects of paclitaxel in lung cancer (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - February 6, 2020 Category: Cancer & Oncology Authors: Ana Rosa Rama Ballesteros Rosa Hern ández Gloria Perazzoli Laura Cabeza Consolaci ón Melguizo Celia V élez Jose Prados Source Type: research

Editorial expression of concern: Cdc6 expression is induced by HPV16 E6 and E7 oncogenes and represses E-cadherin expression
Cancer Gene Therapy, Published online: 06 February 2020; doi:10.1038/s41417-020-0165-zEditorial expression of concern: Cdc6 expression is induced by HPV16 E6 and E7 oncogenes and represses E-cadherin expression (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - February 6, 2020 Category: Cancer & Oncology Authors: E. Faghihloo M. Sadeghizadeh S. Shahmahmoodi T. Mokhtari-Azad Source Type: research

PIK3CA gene aberrancy and role in targeted therapy of solid malignancies
Cancer Gene Therapy, Published online: 28 January 2020; doi:10.1038/s41417-020-0164-0PIK3CA gene aberrancy and role in targeted therapy of solid malignancies (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - January 28, 2020 Category: Cancer & Oncology Authors: Owen Willis Khalil Choucair Abdurahman Alloghbi Laura Stanbery Rex Mowat F. Charles Brunicardi Lance Dworkin John Nemunaitis Source Type: research

Therapeutic effects of oligo-single-stranded DNA mimicking of hsa-miR-15a-5p on multiple myeloma
Cancer Gene Therapy, Published online: 28 January 2020; doi:10.1038/s41417-020-0161-3Therapeutic effects of oligo-single-stranded DNA mimicking of hsa-miR-15a-5p on multiple myeloma (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - January 28, 2020 Category: Cancer & Oncology Authors: Zhongqing Li Lanting Liu Chenxing Du Zhen Yu Yuanyuan Yang Jie Xu Xiaojing Wei Fenghuang Zhan Yongrong Lai Lugui Qiu Mu Hao Source Type: research

Targeting LRIG2 overcomes resistance to EGFR inhibitor in glioblastoma by modulating GAS6/AXL/SRC signaling
Cancer Gene Therapy, Published online: 28 January 2020; doi:10.1038/s41417-020-0163-1Targeting LRIG2 overcomes resistance to EGFR inhibitor in glioblastoma by modulating GAS6/AXL/SRC signaling (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - January 28, 2020 Category: Cancer & Oncology Authors: Minhai Dong Qungen Xiao Jinyang Hu Fangling Cheng Po Zhang Weifeng Zong Qiaoying Tang Xiaopeng Li Feng Mao Yue He Xingjiang Yu Feng Wan Ting Lei Dongsheng Guo Baofeng Wang Source Type: research

Prognostic role of minichromosome maintenance family in multiple myeloma
Cancer Gene Therapy, Published online: 21 January 2020; doi:10.1038/s41417-020-0162-2Prognostic role of minichromosome maintenance family in multiple myeloma (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - January 21, 2020 Category: Cancer & Oncology Authors: Liang Quan Tingting Qian Longzhen Cui Yan Liu Lin Fu Chaozeng Si Source Type: research

RNA N6-methyladenosine modification in solid tumors: new therapeutic frontiers
Cancer Gene Therapy, Published online: 20 January 2020; doi:10.1038/s41417-020-0160-4RNA N6-methyladenosine modification in solid tumors: new therapeutic frontiers (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - January 20, 2020 Category: Cancer & Oncology Authors: Laleh Melstrom Jianjun Chen Source Type: research

Autologous CAR T-cell therapies supply chain: challenges and opportunities?
Cancer Gene Therapy, Published online: 14 January 2020; doi:10.1038/s41417-019-0157-zAutologous CAR T-cell therapies supply chain: challenges and opportunities? (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - January 14, 2020 Category: Cancer & Oncology Authors: Maria M. Papathanasiou Christos Stamatis Matthew Lakelin Suzanne Farid Nigel Titchener-Hooker Nilay Shah Source Type: research

Retraction Note: Blockage of miR-92a-3p with locked nucleic acid induces apoptosis and prevents cell proliferation in human acute megakaryoblastic leukemia
Cancer Gene Therapy, Published online: 13 January 2020; doi:10.1038/s41417-019-0158-yRetraction Note: Blockage of miR-92a-3p with locked nucleic acid induces apoptosis and prevents cell proliferation in human acute megakaryoblastic leukemia (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - January 13, 2020 Category: Cancer & Oncology Authors: M. Sharifi R. Salehi Source Type: research

Ectopia associated MN1 fusions and aberrant activation in myeloid neoplasms with t(12;22)(p13;q12)
Cancer Gene Therapy, Published online: 06 January 2020; doi:10.1038/s41417-019-0159-xEctopia associated MN1 fusions and aberrant activation in myeloid neoplasms with t(12;22)(p13;q12) (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - January 6, 2020 Category: Cancer & Oncology Authors: Tong Wang Xue Chen Shuang Hui Jingbo Ni Ying Yin Wei Cao Yan Zhang Xinyu Wang Xiaoli Ma Panxiang Cao Mingyue Liu Kylan N. Chen Fang wang Yang Zhang Daijing Nie Lili Yuan Hongxing Liu Source Type: research

Identification of folate receptor α (FRα) binding oligopeptides and their evaluation for targeted virotherapy applications
Cancer Gene Therapy, Published online: 06 January 2020; doi:10.1038/s41417-019-0156-0Identification of folate receptor α (FRα) binding oligopeptides and their evaluation for targeted virotherapy applications (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - January 6, 2020 Category: Cancer & Oncology Authors: Sarah L. Hulin-Curtis James A. Davies Davor Nesti ć Emily A. Bates Alexander T. Baker Tabitha G. Cunliffe Dragomira Majhen John D. Chester Alan L. Parker Source Type: research

MyoD1 suppresses cell migration and invasion by inhibiting FUT4 transcription in human gastric cancer cells
Cancer Gene Therapy, Published online: 12 December 2019; doi:10.1038/s41417-019-0153-3MyoD1 suppresses cell migration and invasion by inhibiting FUT4 transcription in human gastric cancer cells (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - December 12, 2019 Category: Cancer & Oncology Authors: Fei Wu Yannan Qin Qiuyu Jiang Jinyuan Zhang Fang Li Qian Li Xiaofei Wang Yi Gao Jiyu Miao Chen Guo Yang Yang Lei Ni Liying Liu Shuqun Zhang Chen Huang Source Type: research

The role of phosphorylation of MLF2 at serine 24 in BCR-ABL leukemogenesis
Cancer Gene Therapy, Published online: 12 December 2019; doi:10.1038/s41417-019-0152-4The role of phosphorylation of MLF2 at serine 24 in BCR-ABL leukemogenesis (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - December 12, 2019 Category: Cancer & Oncology Authors: Juhua Yang Donglin Cao Yanrong Zhang Ruiming Ou Zhao Yin Yanjun Liu Guiping Huang Chunming Gu Shengting Chen Jia Fei Source Type: research

Challenges in assessing solid tumor responses to immunotherapy
Cancer Gene Therapy, Published online: 11 December 2019; doi:10.1038/s41417-019-0155-1Challenges in assessing solid tumor responses to immunotherapy (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - December 11, 2019 Category: Cancer & Oncology Authors: Louis F. Chai Ethan Prince Venu G. Pillarisetty Steven C. Katz Source Type: research

BAG3 regulates multiple myeloma cell proliferation through FOXM1/Rb/E2F axis
Cancer Gene Therapy, Published online: 05 December 2019; doi:10.1038/s41417-019-0154-2BAG3 regulates multiple myeloma cell proliferation through FOXM1/Rb/E2F axis (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - December 5, 2019 Category: Cancer & Oncology Authors: Hua Bai Bing Chen Source Type: research

Correction: A qualitative transcriptional signature for determining the grade of colorectal adenocarcinoma
Cancer Gene Therapy, Published online: 05 December 2019; doi:10.1038/s41417-019-0151-5Correction: A qualitative transcriptional signature for determining the grade of colorectal adenocarcinoma (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - December 5, 2019 Category: Cancer & Oncology Authors: Hailong Zheng Kai Song Yelin Fu Tianyi You Jing Yang Wenbing Guo Kai Wang Liangliang Jin Yunyan Gu Lishuang Qi Wenyuan Zhao Zheng Guo Source Type: research

MicroRNA-200 family expression analysis in metastatic clear cell renal cell carcinoma patients
Cancer Gene Therapy, Published online: 04 November 2019; doi:10.1038/s41417-019-0149-zMicroRNA-200 family expression analysis in metastatic clear cell renal cell carcinoma patients (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - November 4, 2019 Category: Cancer & Oncology Authors: Irina R. Gilyazova Elizaveta A. Klimentova Kirill V. Bulygin Adel A. Izmailov Marina A. Bermisheva Elmira F. Galimova Ruslan I. Safiullin Shamil N. Galimov Valentin N. Pavlov Elsa K. Khusnutdinova Source Type: research

Liposomal delivery of CRISPR/Cas9
Cancer Gene Therapy, Published online: 02 November 2019; doi:10.1038/s41417-019-0141-7Liposomal delivery of CRISPR/Cas9 (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - November 2, 2019 Category: Cancer & Oncology Authors: Shuai Zhen Xu Li Source Type: research

Mechanism and therapeutic prospect of resveratrol combined with TRAIL in the treatment of renal cell carcinoma
Cancer Gene Therapy, Published online: 30 October 2019; doi:10.1038/s41417-019-0150-6Mechanism and therapeutic prospect of resveratrol combined with TRAIL in the treatment of renal cell carcinoma (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - October 30, 2019 Category: Cancer & Oncology Authors: Yan Zeng Feng-di Li Chun-wei Shi Jiang-long Du Yu-jia Xue Xin-yuan Liu Xin Cao Na Wei Source Type: research

Retraction Note: Enhanced suppression of tumor growth using a combination of NK4 plasmid DNA-PEG engrafted cationized dextran complex and ultrasound irradiation
Cancer Gene Therapy, Published online: 30 October 2019; doi:10.1038/s41417-019-0148-0Retraction Note: Enhanced suppression of tumor growth using a combination of NK4 plasmid DNA-PEG engrafted cationized dextran complex and ultrasound irradiation (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - October 30, 2019 Category: Cancer & Oncology Authors: H. Hosseinkhani T. Kushibiki K. Matsumoto T. Nakamura Y. Tabata Source Type: research

The incidence, genetic characteristics, and prognosis of leukemia with concurrent pathogenic fusion genes: a series of 25 cases from a large cohort of leukemia patients
Cancer Gene Therapy, Published online: 23 October 2019; doi:10.1038/s41417-019-0147-1The incidence, genetic characteristics, and prognosis of leukemia with concurrent pathogenic fusion genes: a series of 25 cases from a large cohort of leukemia patients (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - October 23, 2019 Category: Cancer & Oncology Authors: Xue Chen Fang Wang Tong Wang Yang Zhang Xiaoli Ma Lili Yuan Wen Teng Lei Guo Mingyue Liu Ming Liu Jiaqi Chen Daijing Nie Yu Zhang Xiaosu Zhou Mangju Wang Kylan N. Chen Ping Zhu Hongxing Liu Source Type: research

ApoE-modified liposomes mediate the antitumour effect of survivin promoter-driven HSVtk in hepatocellular carcinoma
Cancer Gene Therapy, Published online: 23 October 2019; doi:10.1038/s41417-019-0145-3ApoE-modified liposomes mediate the antitumour effect of survivin promoter-driven HSVtk in hepatocellular carcinoma (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - October 23, 2019 Category: Cancer & Oncology Authors: Xiuli Mu Xi Wang Yan Wei Chaochao Wen Qi Zhang Chunyang Xu Chang Liu Chan Zhang Fanxiu Meng Na Zhao Tao Gong Rui Guo Gongqin Sun Gaopeng Li Hongwei Zhang Qin Qin Jun Xu Xiushan Dong Lumei Wang Baofeng Yu Source Type: research

Identification of genes of four malignant tumors and a novel prediction model development based on PPI data and support vector machines
Cancer Gene Therapy, Published online: 23 October 2019; doi:10.1038/s41417-019-0143-5Identification of genes of four malignant tumors and a novel prediction model development based on PPI data and support vector machines (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - October 23, 2019 Category: Cancer & Oncology Authors: Ming Li Ping Wang Ning Zhang Lu Guo Yuan-Ming Feng Source Type: research

Application of RNA-sequencing to identify transcriptome modification by DCLK1 in colorectal cancer cells
Cancer Gene Therapy, Published online: 21 October 2019; doi:10.1038/s41417-019-0144-4Application of RNA-sequencing to identify transcriptome modification by DCLK1 in colorectal cancer cells (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - October 21, 2019 Category: Cancer & Oncology Authors: Lianna Li Hao Mei Abednego Nii Adom Commey Source Type: research

GATA3 suppresses human fibroblasts-induced metastasis of clear cell renal cell carcinoma via an anti-IL6/STAT3 mechanism
Cancer Gene Therapy, Published online: 21 October 2019; doi:10.1038/s41417-019-0146-2GATA3 suppresses human fibroblasts-induced metastasis of clear cell renal cell carcinoma via an anti-IL6/STAT3 mechanism (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - October 21, 2019 Category: Cancer & Oncology Authors: Qianqian Shi Renfang Xu Guanglai Song Hao Lu Dong Xue Xiaozhou He Ying Xia Source Type: research

Specific glioblastoma multiforme prognostic-subtype distinctions based on DNA methylation patterns
Cancer Gene Therapy, Published online: 16 October 2019; doi:10.1038/s41417-019-0142-6Specific glioblastoma multiforme prognostic-subtype distinctions based on DNA methylation patterns (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - October 16, 2019 Category: Cancer & Oncology Authors: Huihui Ma Chenggang Zhao Zhiyang Zhao Lizhu Hu Fang Ye Hongzhi Wang Zhiyou Fang Yuejin Wu Xueran Chen Source Type: research

A qualitative transcriptional signature for determining the grade of colorectal adenocarcinoma
Cancer Gene Therapy, Published online: 09 October 2019; doi:10.1038/s41417-019-0139-1A qualitative transcriptional signature for determining the grade of colorectal adenocarcinoma (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - October 9, 2019 Category: Cancer & Oncology Authors: Hailong Zheng Kai Song Yelin Fu Tianyi You Jing Yang Wenbing Guo Kai Wang Liangliang Jin Yunyan Gu Lishuang Qi Wenyuan Zhao Zheng Guo Source Type: research

CLEC5A expressed on myeloid cells as a M2 biomarker relates to immunosuppression and decreased survival in patients with glioma
Cancer Gene Therapy, Published online: 08 October 2019; doi:10.1038/s41417-019-0140-8CLEC5A expressed on myeloid cells as a M2 biomarker relates to immunosuppression and decreased survival in patients with glioma (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - October 8, 2019 Category: Cancer & Oncology Authors: Luqing Tong Jiabo Li John Choi Ayush Pant Yuanxuan Xia Christopher Jackson Peidong Liu Li Yi Elias Boussouf Michael Lim Xuejun Yang Source Type: research

Integrative analysis reveals CRHBP inhibits renal cell carcinoma progression by regulating inflammation and apoptosis
Cancer Gene Therapy, Published online: 01 October 2019; doi:10.1038/s41417-019-0138-2Integrative analysis reveals CRHBP inhibits renal cell carcinoma progression by regulating inflammation and apoptosis (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - October 1, 2019 Category: Cancer & Oncology Authors: Kang Yang Yusha Xiao Tao Xu Weimin Yu Yuan Ruan Pengcheng Luo Fan Cheng Source Type: research

Specific driving of the suicide E gene by the CEA promoter enhances the effects of paclitaxel in lung cancer
Cancer Gene Therapy, Published online: 24 September 2019; doi:10.1038/s41417-019-0137-3Specific driving of the suicide E gene by the CEA promoter enhances the effects of paclitaxel in lung cancer (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - September 24, 2019 Category: Cancer & Oncology Authors: Ana Rosa Rama Rosa Hern ández Gloria Perazzoli Laura Cabeza Consolaci ón Melguizo Celia V élez Jose Prados Source Type: research

SOX17, β-catenin and CyclinD1 expression in the endometrioid adenocarcinoma and influence of 5-AZA on expression
Cancer Gene Therapy, Published online: 23 September 2019; doi:10.1038/s41417-019-0135-5SOX17, β-catenin and CyclinD1 expression in the endometrioid adenocarcinoma and influence of 5-AZA on expression (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - September 23, 2019 Category: Cancer & Oncology Authors: Yu-Mei Liao Yang Song Yuan-Kun Li Jie-Hua Du Ying Zhou Source Type: research

Circular RNAs: epigenetic regulators in cancerous and noncancerous skin diseases
Cancer Gene Therapy, Published online: 03 September 2019; doi:10.1038/s41417-019-0130-xCircular RNAs: epigenetic regulators in cancerous and noncancerous skin diseases (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - September 3, 2019 Category: Cancer & Oncology Authors: Abbas Abi Najmeh Farahani Ghader Molavi Seyed Mohammad Gheibi Hayat Source Type: research

Emerging role of exosomes as promising diagnostic tool for cancer
Cancer Gene Therapy, Published online: 03 September 2019; doi:10.1038/s41417-019-0136-4Emerging role of exosomes as promising diagnostic tool for cancer (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - September 3, 2019 Category: Cancer & Oncology Authors: Vijayashree Priyadharsini Jayaseelan Source Type: research

Oncolytic activity of HF10 in head and neck squamous cell carcinomas
Cancer Gene Therapy, Published online: 03 September 2019; doi:10.1038/s41417-019-0129-3Oncolytic activity of HF10 in head and neck squamous cell carcinomas (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - September 3, 2019 Category: Cancer & Oncology Authors: Shinichi Esaki Fumi Goshima Haruka Ozaki Gaku Takano Yoshimi Hatano Daisuke Kawakita Kei Ijichi Takahiro Watanabe Yoshitaka Sato Takayuki Murata Hiromitsu Iwata Yuta Shibamoto Shingo Murakami Yukihiro Nishiyama Hiroshi Kimura Source Type: research

Companion gene mutations and their clinical significance in AML with double mutant CEBPA
Cancer Gene Therapy, Published online: 03 September 2019; doi:10.1038/s41417-019-0133-7Companion gene mutations and their clinical significance in AML with double mutant CEBPA (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - September 3, 2019 Category: Cancer & Oncology Authors: Yang Zhang Fang Wang Xue Chen Yu Zhang Mingyu Wang Hong Liu Wen Teng Panxiang Cao Daijing Nie Xiaoli Ma Tong Wang Peihua Lu Hongxing Liu Source Type: research

Alkaliptosis: a new weapon for cancer therapy
Cancer Gene Therapy, Published online: 30 August 2019; doi:10.1038/s41417-019-0134-6Alkaliptosis: a new weapon for cancer therapy (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - August 30, 2019 Category: Cancer & Oncology Authors: Jiao Liu Feimei Kuang Rui Kang Daolin Tang Source Type: research

SGPL1321 mutation: one main trigger for invasiveness of pediatric alveolar rhabdomyosarcoma
Cancer Gene Therapy, Published online: 27 August 2019; doi:10.1038/s41417-019-0132-8SGPL1321 mutation: one main trigger for invasiveness of pediatric alveolar rhabdomyosarcoma (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - August 27, 2019 Category: Cancer & Oncology Authors: Anna Adamus Nadja Engel Guido Seitz Source Type: research

Synergistic antitumor effect on cervical cancer by rational combination of PD1 blockade and CRISPR-Cas9-mediated HPV knockout
Cancer Gene Therapy, Published online: 27 August 2019; doi:10.1038/s41417-019-0131-9Synergistic antitumor effect on cervical cancer by rational combination of PD1 blockade and CRISPR-Cas9-mediated HPV knockout (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - August 27, 2019 Category: Cancer & Oncology Authors: Shuai Zhen Jiaojiao Lu Yun-Hui Liu Wei Chen Xu Li Source Type: research

Calcium-sensing receptor antagonist NPS-2143 suppresses proliferation and invasion of gastric cancer cells
Cancer Gene Therapy, Published online: 08 August 2019; doi:10.1038/s41417-019-0128-4Calcium-sensing receptor antagonist NPS-2143 suppresses proliferation and invasion of gastric cancer cells (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - August 8, 2019 Category: Cancer & Oncology Authors: Zong-Lin Zhang Zheng-Rong Li Jun-Sheng Li Su-Rong Wang Source Type: research

Cancer immunotherapy using the Fusion gene of Sendai virus
Cancer Gene Therapy, Published online: 06 August 2019; doi:10.1038/s41417-019-0126-6Cancer immunotherapy using the Fusion gene of Sendai virus (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - August 6, 2019 Category: Cancer & Oncology Authors: Jiayu A. Tai Chin Yang Chang Tomoyuki Nishikawa Yasufumi Kaneda Source Type: research

Abnormal expression of menin predicts the pathogenesis and poor prognosis of adult gliomas
Cancer Gene Therapy, Published online: 06 August 2019; doi:10.1038/s41417-019-0127-5Abnormal expression of menin predicts the pathogenesis and poor prognosis of adult gliomas (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - August 6, 2019 Category: Cancer & Oncology Authors: Zhan-Feng Wang Xin-Yu Hong Ling-Yu Zhu Li Zhang Huan Qiu Yuan-Yuan Zhang Ming-Cheng Yuan Xing-Li Zhao Qi-Fan Zheng Guang-Hui Jin Source Type: research

The interaction between microRNA-152 and DNA methyltransferase-1 as an epigenetic prognostic biomarker in HCV-induced liver cirrhosis and HCC patients
Cancer Gene Therapy, Published online: 18 July 2019; doi:10.1038/s41417-019-0123-9The interaction between microRNA-152 and DNA methyltransferase-1 as an epigenetic prognostic biomarker in HCV-induced liver cirrhosis and HCC patients (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - July 18, 2019 Category: Cancer & Oncology Authors: Rady E. El-Araby Mahmoud A. Khalifa Mona M. Zoheiry Manal Y. Zahran Mohamed I. Rady Raafat A. Ibrahim Mohamed D. El-Talkawy Faiza M. Essawy Source Type: research

Viral vector: potential therapeutic for glioblastoma multiforme
Cancer Gene Therapy, Published online: 18 July 2019; doi:10.1038/s41417-019-0124-8Viral vector: potential therapeutic for glioblastoma multiforme (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - July 18, 2019 Category: Cancer & Oncology Authors: Ceera Manikandan Akshita Kaushik Dwaipayan Sen Source Type: research

Notch pathway in ependymoma RELA-fused subgroup: upregulation and association with cancer stem cells markers expression
Cancer Gene Therapy, Published online: 16 July 2019; doi:10.1038/s41417-019-0122-xNotch pathway in ependymoma RELA-fused subgroup: upregulation and association with cancer stem cells markers expression (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - July 16, 2019 Category: Cancer & Oncology Authors: Taciani de Almeida Magalh ães Gustavo Alencastro Veiga Cruzeiro Graziella Ribeiro de Sousa Keteryne Rodrigues da Silva R égia Caroline Peixoto Lira Carlos Alberto Scrideli Luiz Gonzaga Tone Elvis Terci Valera Kleiton Silva Borges Source Type: research

Discovery and validation of methylated-differentially expressed genes in Helicobacter pylori-induced gastric cancer
Cancer Gene Therapy, Published online: 16 July 2019; doi:10.1038/s41417-019-0125-7Discovery and validation of methylated-differentially expressed genes in Helicobacter pylori-induced gastric cancer (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - July 16, 2019 Category: Cancer & Oncology Authors: Duanrui Liu Xiaoli Ma Fei Yang Dongjie Xiao Yanfei Jia Yunshan Wang Source Type: research

MicroRNA-4268 inhibits cell proliferation via AKT/JNK signalling pathways by targeting Rab6B in human gastric cancer
Cancer Gene Therapy, Published online: 15 July 2019; doi:10.1038/s41417-019-0118-6MicroRNA-4268 inhibits cell proliferation via AKT/JNK signalling pathways by targeting Rab6B in human gastric cancer (Source: Cancer Gene Therapy)
Source: Cancer Gene Therapy - July 15, 2019 Category: Cancer & Oncology Authors: Lingyu Zhao Meng Xue Lu Zhang Bo Guo Yannan Qin Qiuyu Jiang Ruifang Sun Juang Yang Lumin Wang Liying Liu Xiaofei Wang Chen Huang Dongdong Tong Source Type: research